Imlygic Injection, Suspension
Product Images NDC 55513-079

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Imlygic (NDC 55513-079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amgen Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1: Injection Administration For Cutaneous Lesions (Imlygic 01)

Figure 1: Injection Administration For Cutaneous Lesions (Imlygic 01)
FDA Label Image

Figure 2: Injection Administration For Subcutaneous Lesions (Imlygic 02)

Figure 2: Injection Administration For Subcutaneous Lesions (Imlygic 02)
FDA Label Image

Figure 3: Injection Administration For Nodal Lesions (Imlygic 03)

Figure 3: Injection Administration For Nodal Lesions (Imlygic 03)
FDA Label Image

Figure 4: Single-use Vial Permanently Inserted Into A Clear Copolyester Plastic Sleeve (Imlygic 04)

Figure 4: Single-use Vial Permanently Inserted Into A Clear Copolyester Plastic Sleeve (Imlygic 04)
FDA Label Image

Figure 5: Single-use Vial Without A Clear Plastic Sleeve (Imlygic 05)

Figure 5: Single-use Vial Without A Clear Plastic Sleeve (Imlygic 05)
FDA Label Image

Imlygic 06

Imlygic 06
This is a description of a medication called IMLYGIC, which comes in a 10¢ PFU/mL Single Use Vial consisting of 1 mL of deliverable containing 10 plaque forming units (PFU), meant for intralesional injection. It is a Suspension for Injection made of lumefantrine and d-sodium bydrogen phosphate dihydrate, with no preservatives and packaged in a natural rubber latex-free container. The text also provides storage instructions for this medication.*
FDA Label Image

Principal Display Panelstore At -70⁰c To -90⁰c (-94⁰f To -130⁰f)talimogene Laherparepvec106 Pfu/ml106 Pfu/mlfor Intralesional Injection Onlybiovex, Inc., A Subsidiary Of Amgen Inc.,one Amgen Center Drive, Thousand Oaks, California 91320-1799rx Onlylot:exp.: (Imlygic 07)

Principal Display Panelstore At -70⁰c To -90⁰c (-94⁰f To -130⁰f)talimogene Laherparepvec106 Pfu/ml106 Pfu/mlfor Intralesional Injection Onlybiovex, Inc., A Subsidiary Of Amgen Inc.,one Amgen Center Drive, Thousand Oaks, California 91320-1799rx Onlylot:exp.: (Imlygic 07)
This appears to be a medication guide and package insert for a drug called IMLYGIC®. It is a suspension for injection containing talimogene laherparepvec at a concentration of 10 PFU/mL and 10 PRU/mL in a single-use vial. The drug is not meant to be diluted and must be stored at a certain temperature range. Detailed prescription information and instructions are available in the package insert.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.